Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,471 | 12,273 | 14,172 | 18,487 | 26,094 |
| Marketable Securities | 582 | N/A | 0 | 45 | 528 |
| Receivables | 479 | 404 | 1,040 | 883 | 524 |
| Inventories | 846 | 1,001 | 874 | 741 | 382 |
| Other current assets | 1,900 | 565 | 200 | 0 | 0 |
| TOTAL | $12,455 | $14,737 | $17,065 | $22,208 | $27,749 |
| Non-Current Assets | |||||
| PPE Net | 1,516 | 5,683 | 5,662 | 5,388 | 3,066 |
| Investments And Advances | 599 | 779 | 1,023 | 865 | 682 |
| Intangibles | 0 | 22 | 334 | 1,654 | 1,398 |
| Other Non-Current Assets | 0 | 0 | 0 | 28 | 111 |
| TOTAL | $2,114 | $6,484 | $7,019 | $7,935 | $5,257 |
| Total Assets | $14,570 | $21,221 | $24,084 | $30,143 | $32,939 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,132 | 1,778 | 1,296 | 1,163 | 1,290 |
| Accounts payable and accrued liabilities | 632 | 626 | 921 | 624 | 459 |
| Accrued Expenses | 1,293 | 741 | 761 | 669 | 924 |
| Other current liabilities | N/A | N/A | 10 | 48 | N/A |
| TOTAL | $3,126 | $3,255 | $3,119 | $2,683 | $2,732 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 746 | 3 | -192 | -91 | -387 |
| TOTAL | $223 | $617 | $702 | $1,117 | $1,048 |
| Total Liabilities | $3,349 | $3,872 | $3,822 | $3,800 | $3,781 |
| Shareholders' Equity | |||||
| Common Shares | 43,841 | 43,342 | 42,439 | 41,787 | 38,286 |
| Retained earnings | -48,302 | -42,200 | -38,157 | -30,530 | -25,132 |
| Other shareholders' equity | 11,137 | 11,086 | 10,861 | 10,978 | 10,567 |
| TOTAL | $11,966 | $17,352 | $20,070 | $26,064 | $28,477 |
| Total Liabilities And Equity | $15,315 | $21,224 | $23,892 | $29,865 | $32,258 |